Hereditary cerebral hemorrhage with amyloidosis - Dutch type (HCHWA-D): A review of the variety in phenotypic expression

Amyloid

Volumn 6, Issue 3, 1999, Pages 215-224

  Bornebroek, Marjolijn ^a   Haan, Joost ^b   Roos, Raymund A C ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Alzheimer's disease; Cerebral amyloid angiopathy; Dementia; Hemorrhage; Hereditary cerebral hemorrhage with amyloidosis Dutch type; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

AMYLOIDOSIS; BRAIN HEMORRHAGE; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; EPILEPSY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE;

EID: 0032823830     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129909007331     Document Type: Review

References (58)

1. 1 Luyendijk W and Schoen JHR (1964). Intracerebral haematomas: a clinical study of 40 surgical cases. Psychiat Neurol Neurochir 67, 445-468
2. 2 Luyendijk W, Bots GTAM, Vegter-van der Vlis M, Went LN and Frangione B (1988). Hereditary cerebral hemorrage caused by cortical amyloid angiopathy. J Neurol Sci 85, 267-280
3. 3 Haan J and Roos RAC (1992). Comparison betwewen the Icelandic and Dutch forms of hereditary cerebral amyloid angiopathy. Clin Neurol Neurosurg 94 (suppl), S82-S83
4. 4 Van Duinen SG, Castano EM, Prelli F, Bots GTAM, Luyendijk W and Frangione B (1987). Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer's disease. Proc Natl Acad USA 84, 5991-5994
5. 5 Van Broeckhoven C, Haan J, Bakker E, Hardy JA, Vanhul W, Wehnert A, Vegter-van der Vlis M and Roos RAC (1990). Amyloid β-protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 248, 1120-1122
6. 6 Jensson O, Gudmundsson G, Arnason A, Blondal H, Petursdottir I, Thorsteinsson L, Grubb A, Lofberg H, Cohen D and Frangione B (1987). Hereditary cystatin C (gamma trace) amyloid angiopathy of the CNS causing cerebral hemorrhage. Acta Neurol Scand 76, 102-114
7. 7 Abrahamson M, Islam M,Q., Szpirer J, Szpirer C and Levan G (1989). The human cystatin C gene (CST3), mutated in hereditary cystatin C amyloid angiopathy, is located on chromosome 20. Hum Genet 82, 223-226
8. 8 Maat-Schieman MLC, Van Duinen SG, Bornebroek M, Haan J and Roos RAC (1996). Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): II - A review of histopathological aspects. Brain Pathology 6, 115-120
9. 9 Fernandez-Madrid Y, Levy E, Marder K and Frangione B (1991). Codon 618 variant of Alzheimer's amyloid gene associated with inhereted cerebral hemorrhage. Ann Neurol 30, 730-733
10. 10 Levy E, Carman MD, Fernandez-Madrid Y, Power MD, Lieberburg I, Van Duinen SG, Bots GTAM, Luyendijk W and Frangione B (1990). Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1126
11. 11 Bakker E, Van Broeckhoven C, Haan J, Voorhoeve E, Van Hul W, Levy E, Lieberburg I, Carman MD, Van Ommen GJB, Frangione B and Roos RAC (1991). DNA diagnosis for hereditary cerebral hemorrhage with amyloidosis (Dutch type). Am J Hum Genet 49, 518-521
12. 12 Graffagnino C, Herbstreith MH, Roses AD and Alberts MJ (1994). A molecular genetic study of intracerebral hemorrhage. Arch Neurol 51, 981-984
13. 13 Haan J, Algra P and Roos RAC (1990). Hereditary cerebral hemorrhage with amyloidosis - Dutch type: clinical and computed tomographic analysis of 24 cases. Arch Neurol 47, 649-653
14. 14 Bornebroek M, Haan J, Maat-Schieman MLC, Van Duinen SG and Roos RAC (1996). Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): I - A review of the clinical, radiologic and genetic aspects. Brain Pathology 6, 111-114
15. 15 Wattendorf AR, Frangione B, Luyendijk W and Bots GTAM (1995). Hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D): clinicopathological studies. J Neurol Neurosurg Psychiatry 58, 699-705
16. 16 Westendorp R, Haan J, Bakker E, Timmers WF and Roos RAC (1997). Mortality from hereditary cerebral hemorrhage with amyloidosis - Dutch type: Impact of sex, year of birth and line of transmission. Brain 120, 2243-2249
17. 17 Bornebroek M, van Buchem MA, Haan J, Brand J, Lanser JKB, Bruïne FT and Roos RAC (1996). Hereditary cerebral hemorrhage with amyloidosis - Dutch type: better correlation of cognitive deterioration with advancing age than with the number of focal lesions or white matter hyperintensities. Alz Dis Assoc Dis 10, 224-231
18. 18 Bornebroek M, Haan J, van Buchem MA, Lanser JKB, de Vries-vd Weerd MAC, Zoetewey M and Roos RAC (1996). White matter lesions and cognitive deterioration in presymptomatic carriers of the amyloid precursor protein gene codon 693 mutation. Arch Neurol 53, 43-48
19. 19 O'Brien MD (1994). How does cerebrovascular disease cause dementia? Dementia 5, 133-136
20. 20 Haan J, Roos RAC, Algra P, Lanser JKB, Bots GTAM and Vegter-van der Vlis M (1990). Hereditary cerebral hemorrhage with amyloidosis - Dutch type: Magnetic resonance imaging of seven cases. Brain 113, 1251-1267
21. 21 Haan J, Van Broeckhoven C, van Duijn CM, Voorhoeve E, Van Harskamp F, Van Swieten JC, Maat-Schieman MLC, Roos RAC and Bakker E (1994). The apolipoprotein E Î4 allele does not influence the clinical expression of the amyloid precursor protein gene codon 693 or 692 mutations. Ann Neurol 36, 434-437
22. 22 Haan J, Roos RAC and Bakker E (1995). No protective effect of apolipoprotein E Î2 allele in Dutch hereditary cerebral amyloid angiopathy [letter]. Ann Neurol 37, 282
23. 23 Bornebroek M, Haan J, Van Duinen SG, Maat-Schieman MLC, van Buchem MA, Bakker E, Van Broeckhoven C and Roos RAC (1997). Dutch hereditary cerebral amyloid angiopathy: structural lesions and APOE genotype. Ann Neurol 41, 695-698
24. 24 Wragg M, Hutton M, Talbot C, Busfield F, Han SW, Lendon C, Clark RF, Morris JC, Edwards D, Goate A, Pfeiffer E, Crook R, Prihar G, Phillips H, Baker M, Hardy J, Rossor M, Houlden H, Karran E, Roberts G and Craddock N (1996). Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 347, 509-512
25. 25 Bornebroek M, Haan J, Backhovens H, Deutz P, van Buchem MA, van den Broeck M, Bakker E, Roos RAC and Van Broeckhoven C (1997). Presenilin 1 polymorphism and hereditary cerebral hemorrhage with amyloidosis Dutch type. Ann Neurol 42, 108-110
26. 26 Van Duinen SG, Maat-Schieman MLC, Bruyn JA, Haan J and Roos RAC (1995). Cortical tissue of patients with hereditary cerebral hemorrhage with amyloidosis (Dutch) contains various extracellular matrix deposits. Lab Invest 73, 183-189
27. 27 Maat-Schieman MLC, Van Duinen SG, Haan J and Roos RAC (1992). Morphology of cerebral plaque-like lesions in hereditary cerebral hemorrhage with amyloidosis (Dutch). Acta Neuropathol 84, 674-679
28. 28 Maat-Schieman MLC, Rozemuller AJ, Van Duinen SG, Haan J, Eikelenboom P and Roos RAC (1994). Microglia in diffuse plaques in hereditary cerebral hemorrhage with amyloidosis (Dutch). An immunohistochemical study. J Neuropathol Exp Neurol 53, 483-491
29. 29 Masters CL, Simms G, Weinman NA, Multhaup G and Beyreuther K (1985). Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc Natl Acad Sci USA 82, 4245-4249
30. 30 Barrow CJ and Zagorski MG (1991). Solution structures of β peptide and its constituent fragments: relation to amyloid deposition. Science 253, 179-181
31. 31 Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C and Glabe C (1992). Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptides analogs. J Biol Chem 267, 546-554
32. 32 Jarrett JT, Berger EP and Lansbury PT (1993). The carboxy terminus of β amyloid is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697
33. 33 Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N and Ihara Y (1994). Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13, 45-53
34. 34 Kang J, Lemaire H, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K, Multhaup G, Beyreuther K and Muller-Hill B (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 325, 733-736
35. 35 Tanzi RE, Gusella JF, Watkins PC, Bruns GAP, St George-Hyslop P, Van Keuren ML, Patterson D, Pagan S, Kurnitt DM and Neve RL (1987). Amyloid β gene: cDNA, mRNA distribution, and genetic linkage near Alzheimer locus. Science 235, 880-884
36. 36 Yoshikai S, Sasaki H, Doh-ura K, Furuya H and Sakaki Y (1990). Genomic organisation of the human amyloid β-protein precursor gene. Gene 87, 257-263
37. 37 Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F and Cordell B (1988). A new A4 amyloid mRNA contains a domain homologues to serine protease inhibitors. Nature 331, 525-532
38. 38 Van Nostrand WE, Wagner SL, Suzuki M, Choi BH, Farrow JS, Geddes JW, Cotman CW and Cunnigham DD (1989). Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Nature 341, 546-549
39. 39 Schmaier AH, Dahl LD, Rozemuller AJ, Roos RAC, Wagner SL, Chung R and Van Nostrand WE (1993). Protease nexin-2 / amyloid β protein precursor: a tight-binding inhibitor of coagulation factor IXa. J Clin Invest 92, 2540-2545
40. 40 Smith RP, Higuchi DA and Broze J (1990). Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science 248, 1126-1128
41. 41 Van Nostrand WE, Schmaier AH and Wagner SL (1992). Potential role of protease nexin-2/amyloid β-protein precursor as a cerebral anticoagulant. Ann N Y Acad Sci 674, 243-252
42. 42 Van Nostrand WE, Wagner SL, Farrow JS and Cunnigham DD (1990). Immunopurification and protease inhibitory properties of protease nexin-2/amyloid beta-protein precursor. J Biol Chem 265, 9591-9594
43. 43 Bornebroek M, von dem Borne PAKr, Haan J, Meijers JCM, Van Nostrand WE and Roos RAC (1998). Binding of β precursor protein to coagulation factor XIa in patients with hereditary cerebral hemorrhage with amyloidosis Dutch type. J Neurol 245, 111-115
44. 44 Van Nostrand WE, Wagner SL, Haan J, Bakker E and Roos RAC (1992). Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis-Dutch type share a decrease in cerebrospinal fluid levels of amyloid β-protein precursor. Ann Neurol 32, 215-218
45. 45 Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Olterdorf T, McClure D and Ward PJ (1990). Cleavage of amyloid β protein during constitutive processing of its precursor. Science 248, 122-1124
46. 46 Citron M, Teplow DB and Selkoe DJ (1995). Generation of amyloid β protein from its precursor is sequence specific. Neuron 14, 661-670
47. 47 Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, Van Harskamp F, Warren A, McInnes MG, Antonarakis SE, Martin JJ, Hofman A and Van Broeckhoven C (1992). Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nature Genet 1, 218-221
48. 48 Bugiani O, Padovani A, Magoni M, Andora G, Sgarzi M, Savoiardo A, Bizzi G, Giaccone G, Rossi G and Tagliavini F (1998). An Italian type of HCHWA. Neurobiol Aging S238 (Abstract)
49. 49 Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J and Mullan M (1991). Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353, 844-846
50. 50 Murrell J, Farlow M, Ghetti B and Benson MD (1991). A mutation in the amyloid precursor protein gene associated with hereditary Alzheimer's disease. Science 254, 97-99
51. 51 Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance MA, Roses A, Williamson R, Rossor M, Owen M and Hardy J (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 728-730
52. 52 Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B and Lannfelt L (1992). A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genet 1, 345-347
53. 53 Hardy J (1997). Amyloid, presenilins and Alzheimer's disease. Trends Neurosci 20, 154-159
54. 54 Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I and Selkoe DJ (1992). Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360, 672-674
55. 55 Suzuki N, Cheung TT, Cai X, Odaka A, Otvos JrL, Eckman C, Golde TE and Younkin SG (1994). An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264, 1336-1340
56. 56 De Jonghe C, Zehr C, Yager D, Prada C, Younkin S, Hendriks L, Vanbroeckhoven C and Eckman C (1998). Flernisch and Dutch mutations in amyloid β precursor protein have different effects on amyloid β secretion. Neurobiol Dis 4, 281-286
57. 57 Bird TD and Bennett RL (1995). Why do DNA testing? practical and ethical implications of new neurogenetic tests. Ann Neurol 38, 141-146
58. 58 Tibben A, Niermeijer MF, Roos RAC, Vegter-van der Vlis M, Frets PG, Van Ommen GJB, van de Kamp JJP and Verhage F (1992). Understanding the low uptake of presymptomatic DNA-testing for Huntington's disease. Lancet 340, 1416